Literature DB >> 12812824

Geographic variation within the United States in the incidence of hepatocellular carcinoma.

Jessica A Davila1, Nancy J Petersena, Harlan A Nelson, Hashem B El-Serag.   

Abstract

Geographic variation in hepatocellular carcinoma (HCC) has not been previously studied in the United States. Using data collected by the Surveillance, Epidemiology, and End Results registries (SEER) and the 1990 Behavioral Risk Factor Surveillance System (BRFSS), we analyzed incidence and risk factors for HCC in nine geographic regions in the United States. We identified all individuals with HCC during 1975-1998 in five states (Connecticut, Iowa, Utah, New Mexico, and Hawaii) and four metropolitan areas (Detroit-Metropolitan, San Francisco-Oakland, Seattle-Puget Sound, and Atlanta-Metropolitan). Age-adjusted incidence rates were calculated for each geographic region. The association between HCC incidence and geographic regions were examined in Poisson multivariate regression model controlling for age, gender, race, and year of diagnosis. Hierarchical linear modeling was also used to examine these associations while adjusting for potential clustering of persons with similar characteristics within geographic regions, and to assess the effect of the prevalence of smoking, alcohol use, obesity, and diabetes in the underlying population in these geographical regions. A total of 11,547 persons with HCC were examined. Hawaii had the highest age-adjusted incidence rate (4.6), followed by San Francisco-Oakland (3.2), New Mexico (2.0), Detroit-Metropolitan (1.9), Seattle-Puget Sound (1.8), Atlanta-Metropolitan (1.7), Connecticut (1.6), Iowa (1.1), and Utah (1.0); all rates per 100,000. Whites had an age-adjusted incidence rate of 1.5, Blacks 3.2, and other races "Asian, American Indian, Pacific Islander" 7.0. However, Blacks and "other races" in Seattle-Puget Sound had higher age-adjusted incidence rates (4.4 and 8.2, respectively) than Blacks and other races in any other registry, while Whites in Hawaii had a higher rate (2.5) than Whites in any other registry. In general, men had a two to three times higher age-adjusted incidence rate than women. However, Hawaiian men had significantly higher age-adjusted rates (7.0) than men in other regions, while Utah had the lowest rates of HCC in men (1.5). Adjusting for variations in ethnicity, gender, age, and time of diagnosis, the Poisson regression analysis showed persistent geographic differences in HCC as well as a change in the order with New Mexico having the highest HCC incidence followed San Francisco-Oakland. Hierarchical linear modeling confirmed geographic variations in HCC but failed to show a significant effect for the prevalence of smoking, alcohol use, obesity, and diabetes in the underlying population. Significant geographic variation in HCC incidence exist in the United States. These variations are only partly explained by differences in age, gender, race, and year of diagnosis.

Entities:  

Mesh:

Year:  2003        PMID: 12812824     DOI: 10.1016/s0895-4356(02)00605-4

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  14 in total

1.  Viral hepatitis in Hawai'i--differing perspectives.

Authors:  Alan D Tice; Michael Bannan; Kay Bauman; Tarquin Collis; Alba Hall; William Haning; Shoshana Hannemann; C Bradley Hare; Joseph Humphry; Robert Jao; Carroll Leevy; Heather Lusk; Edward Ochoa; Neal Palafox; Nancy Withers; Kenneth Akinaka
Journal:  Hawaii Med J       Date:  2010-04

Review 2.  Hepatocellular carcinoma: epidemic and treatment.

Authors:  Jill Allen; Alan Venook
Journal:  Curr Oncol Rep       Date:  2004-05       Impact factor: 5.075

3.  Hepatitis B and alcohol affect survival of hepatocellular carcinoma patients.

Authors:  Linda-L Wong; Whitney-M Limm; Naoky Tsai; Richard Severino
Journal:  World J Gastroenterol       Date:  2005-06-21       Impact factor: 5.742

4.  The Impact of Race on Survival After Hepatocellular Carcinoma in a Diverse American Population.

Authors:  Patricia D Jones; Carlos Diaz; Danlu Wang; Joselin Gonzalez-Diaz; Paul Martin; Erin Kobetz
Journal:  Dig Dis Sci       Date:  2017-12-23       Impact factor: 3.199

5.  Local geographic variation in chronic liver disease and hepatocellular carcinoma: contributions of socioeconomic deprivation, alcohol retail outlets, and lifestyle.

Authors:  Jacqueline M Major; James D Sargent; Barry I Graubard; Heather A Carlos; Albert R Hollenbeck; Sean F Altekruse; Neal D Freedman; Katherine A McGlynn
Journal:  Ann Epidemiol       Date:  2013-11-21       Impact factor: 3.797

6.  Genetic susceptibility to chronic hepatitis is inherited codominantly in Helicobacter hepaticus-infected AB6F1 and B6AF1 hybrid male mice, and progression to hepatocellular carcinoma is linked to hepatic expression of lipogenic genes and immune function-associated networks.

Authors:  Alexis García; Melanie M Ihrig; Rebecca C Fry; Yan Feng; Sandy Xu; Samuel R Boutin; Arlin B Rogers; Suresh Muthupalani; Leona D Samson; James G Fox
Journal:  Infect Immun       Date:  2008-02-19       Impact factor: 3.441

7.  Viral hepatitis markers in liver tissue in relation to serostatus in hepatocellular carcinoma.

Authors:  Brenda Y Hernandez; Xuemei Zhu; Sandi Kwee; Owen T M Chan; Naoky Tsai; Gordon Okimoto; David Horio; Katherine A McGlynn; Sean Altekruse; Linda L Wong
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-08-27       Impact factor: 4.254

8.  Malignant liver tumors in South African children: a national audit.

Authors:  S W Moore; A Davidson; G P Hadley; M Kruger; J Poole; D Stones; L Wainwright; G Wessels
Journal:  World J Surg       Date:  2008-07       Impact factor: 3.352

9.  Gene profiling, biomarkers and pathways characterizing HCV-related hepatocellular carcinoma.

Authors:  Valeria De Giorgi; Alessandro Monaco; Andrea Worchech; Marialina Tornesello; Francesco Izzo; Luigi Buonaguro; Francesco M Marincola; Ena Wang; Franco M Buonaguro
Journal:  J Transl Med       Date:  2009-10-12       Impact factor: 5.531

10.  Food Environments and Hepatocellular Carcinoma Incidence.

Authors:  Mimi Ton; Michael J Widener; Peter James; Trang VoPham
Journal:  Int J Environ Res Public Health       Date:  2021-05-27       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.